Skip To Main Content
April M. Jorge on Muck Rack

April M. Jorge

As seen in: Arthritis & Rheumatology, Wiley Online Library, Arthritis Research & Therapy, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, The New England Journal of Medicine, The Lancet, Annals of Internal Medicine, The Journal of Immunology, The Journal of Rheumatology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with April M.

Contact April M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5 mg/kg Weight‐Based Dosing Cutoff

|
By April M. Jorge
| Wiley Online Library Verified
Supporting Information Filename Description art70062-sup-0001-Disclosureform.pdfPDF document, 218.5 KB Disclosure Form
Open in Who Shared Issue with article?

Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5‐mg/kg Weight‐Based Dosing Cutoff

|
By April M. Jorge, Mass General Brigham
| Wiley Online Library Verified
Editorial Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5-mg/kg Weight-Based Dosing Cutoff April Jorge, Corresponding Author April Jorge Division of Rheumatology, Inflammation, and Immunity, Massachusetts General Hospital, Mass General Brigham and Harvard Medical School, Boston 1Division of Rheumatology, Inflammation, and Immunity, Massachusetts General Hospital, Mass General Brigham and Harvard Medical School, Boston.
Open in Who Shared Issue with article?

Renal Replacement Therapy in Lupus Nephritis-Related End‐Stage Kidney Disease: A Systematic Review and Meta‐Analysis

|
By Hassan Kawtharany, April M. Jorge, Muayad Azzam, Christie M Bartels
| Wiley Online Library Verified
INTRODUCTION Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder with a prevalence of approximately 72 per 100,000 individuals in the United States.1 SLE affects various organs, including the skin, joints, kidneys, central nervous system, and cardiovascular (CV) system. Lupus nephritis (LN), a severe manifestation of SLE, occurs in nearly half of patients and is associated with a 10-year mortality rate of up to 30%.
Open in Who Shared Issue with article?
See all 28 licensed articles (29 Total)